Xenon Pharmaceuticals XENE
$37.04 −$0.52 (-1.38%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $37.04 0.00%
Open$37.22
Prev close$37.56
Day range$36.81 – $37.97
Volume1.09M
Market cap$3.64B
P/E (TTM)–
Dividend yield–
XENE Stock News
Headlines matching Xenon Pharmaceuticals or the XENE ticker, most recent first.
- Bloom Burton Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Cuts Target Price to $71 Negative
- A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $60 to $90
- Wells Fargo Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $69
- A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $74 to $86
- A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $81 to $90
- Stifel Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $86
- J.P. Morgan Remains a Buy on Xenon (XENE)
- J.P. Morgan Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $82
- H.C. Wainwright Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $74
- A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $63 to $80.65
- A Quick Look at Today's Ratings for Xenon Pharmaceuticals(XENE.US), With a Forecast Between $74 to $80.65
- H.C. Wainwright Remains a Buy on Xenon (XENE)
- J.P. Morgan Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $82 Positive
- J.P. Morgan Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Raises Target Price to $80 Positive
- Stifel Maintains Xenon Pharmaceuticals(XENE.US) With Buy Rating, Maintains Target Price $89
No comments yet — be the first to weigh in on XENE.
Sign in to join the discussion.